CooperSurgical, Inc.

12 articles about CooperSurgical, Inc.

• Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing

  2/9/2024

  CooperSurgical today announced that they have partnered to offer families of Cord Blood Registry® (CBR®) exclusive newborn genetic screening panels.

• Cord Blood Registry® Announces Thought Leadership Role at Cord Blood Connect

  9/8/2023

  CooperSurgical, a global leader in fertility and women's health, announced that Cord Blood Registry® will have a key role in the upcoming Cord Blood Connect meeting from September 8th – 11th, which is the annual meeting of the Cord Blood Association.

• CooperSurgical® and Ostro Named Best Patient Education Solution in the 7th Annual MedTech Breakthrough Awards

  5/16/2023

  CooperSurgical, a global leader in women's healthcare, and Ostro, a healthcare engagement platform for consumers and healthcare providers, have been selected as "Best Patient Education Solution" in the 7th annual MedTech Breakthrough Awards.

• CooperSurgical® Announces More than 11,000 Families Have Enrolled in Newborn Possibilities Program®

  1/5/2023

  CooperSurgical, a global leader in fertility and women's health, shared that more than 11,000 families have enrolled in the Newborn Possibilities Program® through their Cord Blood Registry® brand.

• CooperSurgical Acquires Embryo OptionsBest-in-class digital solution helps IVF clinics improve efficiency and educate patients about embryo management

  1/5/2021

  CooperSurgical, a leading provider of women’s health care solutions, has acquired Embryo Options, an established leader in cryo-storage software solutions for clinics and patients.

• CooperSurgical and NYU Langone Fertility Center Announce Study Data Showing Significant Increase in Ongoing Pregnancy and Live Birth Rates with Genetic Test Using Artificial Intelligence (PGTai 2.0 platform) for Patients Undergoing IVF

  10/19/2020

  Data from NYU LangoneFertility Center Study Presented at American Society of Reproductive Medicine Annual Meeting

• Teva Announces Completion of PARAGARD Divestiture to CooperSurgical

  11/2/2017

  This transaction includes Teva's manufacturing facility in Buffalo, NY, which produces PARAGARD exclusively.

• CooperSurgical, Inc. Acquires Research Instruments Limited for $51 Million

  12/31/2015

• FDA Warns CooperSurgical, Inc. About Texas Manufacturing Plant

  5/31/2013

• CooperSurgical, Inc. Launches the New MityOne&#0174 Vacuum-Assisted Delivery System

  2/28/2013

• CooperSurgical, Inc. Selects Xactly to Support Enterprise Sales

  5/1/2012

• American Medical Systems, Inc. Announces Sale of Her Option(R) Global Endometrial Ablation Product Line to CooperSurgical, Inc. for $20.5 Million

  2/17/2010